Advisors Capital Management LLC Acquires 73,281 Shares of Sabra Healthcare REIT, Inc. $SBRA

Advisors Capital Management LLC raised its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 3.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,382,935 shares of the real estate investment trust’s stock after purchasing an additional 73,281 shares during the period. Advisors Capital Management LLC owned 0.96% of Sabra Healthcare REIT worth $45,133,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in SBRA. Founders Capital Management bought a new position in shares of Sabra Healthcare REIT during the third quarter valued at approximately $28,000. Danske Bank A S bought a new position in shares of Sabra Healthcare REIT during the third quarter valued at approximately $30,000. Larson Financial Group LLC increased its position in shares of Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 553 shares in the last quarter. First Horizon Corp bought a new stake in shares of Sabra Healthcare REIT during the fourth quarter valued at approximately $44,000. Finally, Covestor Ltd increased its position in shares of Sabra Healthcare REIT by 23,720.0% during the third quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust’s stock valued at $45,000 after acquiring an additional 2,372 shares in the last quarter. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Price Performance

Shares of SBRA opened at $20.09 on Friday. Sabra Healthcare REIT, Inc. has a twelve month low of $17.04 and a twelve month high of $21.07. The company has a quick ratio of 4.29, a current ratio of 4.29 and a debt-to-equity ratio of 0.90. The firm has a 50 day moving average of $20.21 and a 200 day moving average of $19.27. The company has a market capitalization of $5.07 billion, a P/E ratio of 31.39, a price-to-earnings-growth ratio of 1.59 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The company had revenue of $201.35 million during the quarter, compared to analysts’ expectations of $201.97 million. During the same quarter in the prior year, the business posted $0.36 EPS. The company’s revenue for the quarter was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 27th. Investors of record on Friday, February 13th were issued a $0.30 dividend. The ex-dividend date was Friday, February 13th. This represents a $1.20 annualized dividend and a yield of 6.0%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 187.50%.

Analysts Set New Price Targets

Several brokerages recently weighed in on SBRA. Truist Financial raised their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research report on Friday, March 13th. UBS Group raised their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Thursday, February 19th. Wall Street Zen downgraded shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Friday, January 23rd. Cantor Fitzgerald raised their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Tuesday, February 17th. Finally, Citizens Jmp raised their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 18th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, Sabra Healthcare REIT has an average rating of “Moderate Buy” and an average price target of $22.00.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.